Login
-
- January 9, 2026 – OAC Letter to Aetna on ESG Coverage
- January 29, 2026 – Obesity Action Coalition Supports Medical Spa Oversight
- February 2, 2026 – OCAN Open Letter to Secretary Hegseth
- February 4, 2026 – OAC Urges Senate Labor Committee to Pass NJ SB 1631
- February 4, 2026 – Florida: OAC Response to DMS Fiscal Analysis for HB 977
- February 9, 2026 – Kentucky: OAC Supports Medicaid Coverage of OMs
- February 16, 2026 – OAC Open Letter to MAHA
- February 23, 2026 – Kentucky: OAC Comments to MOAB
- February 26, 2026 – OAC Supports NH SB 445
- February 26, 2026 – Obesity Groups Support Medicaid Coverage for Comprehensive Obesity Care & Urge Passage of SB 3195 and HB 2456
- March 2, 2026 – Ohio: Leading Groups Ask Gov. DeWine to Remove Prohibition Against Medicaid Coverage for OMs
- March 2, 2026 – Rhode Island: Obesity Groups Oppose Gov. McKee’s Proposal to Eliminate Medicaid Coverage for OMs
- March 4, 2026 – Massachusetts: Obesity Groups Urge State Policymakers to Maintain GIC and MassHealth Coverage for Comprehensive Obesity Care
- March 17, 2026 – Minnesota: Obesity Groups Oppose Efforts to Eliminate Medical Assistance Coverage for FDA-Approved Obesity Management Medications
- March 19, 2026 – OCAN Letter to HHS Appropriations re DNPAO
- March 31, 2026 – OAC Urges Southwest to Improve Implementation of COS Policy
- April 6, 2026 – Obesity Groups Support Comprehensive Obesity Treatment Health Insurance Coverage in New York
- April 7, 2026 – Obesity Groups Support Medicaid Coverage of FDA-Approved Obesity Management Medications in Louisiana
- April 7, 2026 – Obesity Groups Oppose Budget Proposal Eliminating Rhode Island Medicaid Coverage for FDA-Approved Obesity Management Medications
- April 10, 2026 – Obesity Groups Support Louisiana State Employee Health Plan Coverage of FDA-Approved GLP-1s, While Opposing Coverage for Unregulated Compounded GLP1s
- April 10, 2026 – Obesity Groups’ Joint Letter to NY Governor Hochul Supporting Obesity Care Coverage
- April 13, 2026 – FY27 Senate LHHS Appropriations Request Letter
- April 14, 2026 – Obesity Groups Support New Hampshire Senate Bill 455 to Restore Medicaid Coverage for FDA-Approved Obesity Management Medications
- April 16, 2026 – Obesity Groups Support Texas Medicaid Department Participation in the CMS BALANCE Model
- April 17, 2026 – Obesity Groups Support Nevada Medicaid Coverage of FDA-Approved Obesity Management Medications
- April 27, 2026 – OAC Supports Florida Medicaid Department Participation in the CMS BALANCE Model
- April 28, 2026 – Obesity Groups Support Passage of Illinois SB 692 to Provide Medicaid Coverage for IBT Services and Establish a Framework for Coverage of FDA-Approved Obesity Management Medications
- May 6, 2026 – OAC Comments on ICD-10-CM Classification for Hypothalamic Obesity
- May 13, 2026 – Obesity Groups Oppose Pennsylvania Decision to Eliminate Comprehensive Obesity Treatment for Medicaid Enrollees
- May 15, 2026 – USPSTF Liver Fibrosis Topic Nomination Screening in Obesity
- June 1, 2026 – OAC Supports Ohio HB 388 Renewing Access to Obesity Medications for Ohio State Employees
- June 17, 2026 – Obesity Groups Joint Statement Re: MassHealth and GIC Coverage
- June 18, 2026 – Obesity Groups Oppose Virginia SEHP Requirements for GLP 1
- June 24, 2026 – OAC Letter to Milwaukee Healthcare System Re: OM Coverage
- June 26, 2026 – OAC Comments on Obesity and Drug Dosing Clinical Pharmacology Considerations
- June 30, 2026 – Obesity Groups Support Medicare GLP1 Bridge Program and Comprehensive Obesity Care
- July 3, 2026 – OAC Supports ESG Coverage in United Healthcare’s Bariatric Surgery Medical Policy
- July 7, 2026 – OAC Comments on Pharmacy Compounding Advisory Meeting
- August 14, 2026 – OAC Letter to Senate Finance Committee on Commonsense Policy Options to Lower Drug Prices for Patients
- August 21, 2026 – OAC Letter to Starbucks CEO and CFO
- August 25, 2026 – Obesity Groups Urge CA to Restore GLP-1 Coverage in the Medi-Cal Program
- August 31, 2026 – OAC Comment Letter to DHA Regarding CMS-1850-P
- September 2, 2026 – OAC Letter to PepsiCo
- September 2, 2026 – Obesity Groups Urge PA’s Pharmacy & Therapeutics Committee to Reinstate Medicaid Coverage for Obesity Medications
- September 15, 2026 – Obesity Groups Urge OHIC to Address Harms of Eliminating RI Medicaid Coverage for OMs
- October 12, 2026 – OAC Provides Recommendations to CMS for Strengthening the RAPID Pathway Program
Public Policy Comments